Bausch Health Companies Inc. Common Stock (BHC)

R&D Expenses

$634.00M

TTM · Period ending: · USD

BHC logo

BHC R&D Expenses

Latest reported$634.00M
BHC TTM R&D Expenses ($0.00 → $634.00M)
High-resolution chart · PNG

BHC r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bausch Health Companies Inc. Common Stock R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
634,000,000
620,000,000
600,000,000
712,000,000
626,000,000
626,000,000
634,000,000
623,000,000
615,000,000
612,000,000
604,000,000
594,000,000
574,000,000
546,000,000
530,000,000
510,000,000
498,000,000
486,000,000
473,000,000
483,000,000
477,000,000
476,000,000
485,000,000
503,000,000
512,000,000
521,000,000
516,000,000
487,000,000
470,000,000
440,000,000
415,000,000
384,000,000
358,000,000
359,000,000
366,000,000
369,000,000
420,000,000
451,000,000
455,000,000
563,500,000
533,100,000
488,200,000
440,000,000
297,600,000
255,100,000
248,900,000
266,400,000
262,200,000
376,100,000
325,700,000
276,200,000
241,465,000
232,935,000
230,714,000
228,920,000
330,732,000
183,738,000
179,223,000
172,887,000
90,023,000
86,845,000
106,339,000
157,556,000
156,805,000
165,709,000
173,143,000
120,784,000
98,507,000
93,973,000
71,040,000
92,844,000
106,033,000
118,039,000
124,727,000
118,117,000
117,237,000
112,913,000
102,868,000
95,474,000
93,829,000
87,392,000
91,742,000
89,901,000
84,183,000
81,918,000
74,996,000
72,500,000
77,612,000
80,572,000
86,555,000
86,570,000
73,030,000
67,048,000
59,688,000
52,150,000
53,701,000
51,093,000
50,553,000
51,492,000
41,576,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.